Report: Developing Opportunities within Haemonetic
Post# of 301275
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Haemonetics Corporation (NYSE: HAE ), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ), Xperi Corporation (NASDAQ: XPER ), MoneyGram International Inc. (NASDAQ: MGI ), Boot Barn Holdings, Inc. (NYSE: BOOT ), and Green Dot Corporation (NYSE: GDOT ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
HAE DOWNLOAD: http://Fundamental-Markets.com/register/?so=HAE ARNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARNA XPER DOWNLOAD: http://Fundamental-Markets.com/register/?so=XPER MGI DOWNLOAD: http://Fundamental-Markets.com/register/?so=MGI BOOT DOWNLOAD: http://Fundamental-Markets.com/register/?so=BOOT GDOT DOWNLOAD: http://Fundamental-Markets.com/register/?so=GDOT
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Haemonetics Corporation (NYSE: HAE ), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ), Xperi Corporation (NASDAQ: XPER ), MoneyGram International Inc. (NASDAQ: MGI ), Boot Barn Holdings, Inc. (NYSE: BOOT ), and Green Dot Corporation (NYSE: GDOT ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 11th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
HAEMONETICS CORPORATION (HAE) REPORT OVERVIEW
Haemonetics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Haemonetics reported revenue of $234.04MM vs $227.84MM (up 2.72%) and basic earnings per share -$0.12 vs $0.30. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Haemonetics reported revenue of $886.12MM vs $908.83MM (down 2.50%) and basic earnings per share -$0.51 vs -$1.09. Haemonetics is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $2.93 and is expected to report on May 14th, 2019.
To read the full Haemonetics Corporation (HAE) report, download it here: http://Fundamental-Markets.com/register/?so=HAE
-----------------------------------------
ARENA PHARMACEUTICALS, INC. (ARNA) REPORT OVERVIEW
Arena Pharmaceuticals' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Arena Pharmaceuticals reported revenue of $1.76MM vs $1.66MM (up 5.72%) and basic earnings per share -$0.80 vs -$0.90. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Arena Pharmaceuticals reported revenue of $21.34MM vs $92.16MM (down 76.85%) and basic earnings per share -$2.77 vs -$0.93. Arena Pharmaceuticals is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.77. The estimated EPS forecast for the next fiscal year is -$3.23 and is expected to report on March 13th, 2019.
To read the full Arena Pharmaceuticals, Inc. (ARNA) report, download it here: http://Fundamental-Markets.com/register/?so=ARNA
-----------------------------------------
XPERI CORPORATION (XPER) REPORT OVERVIEW
Xperi's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Xperi reported revenue of $65.53MM vs $67.26MM (down 2.56%) and basic earnings per share -$0.67 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Xperi reported revenue of $373.73MM vs $259.57MM (up 43.98%) and basic earnings per share -$1.15 vs $1.14. Xperi is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018.
To read the full Xperi Corporation (XPER) report, download it here: http://Fundamental-Markets.com/register/?so=XPER
-----------------------------------------
MONEYGRAM INTERNATIONAL INC. (MGI) REPORT OVERVIEW
MoneyGram International's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, MoneyGram International reported revenue of $380.00MM vs $386.10MM (down 1.58%) and basic earnings per share $0.11 vs $0.14 (down 21.43%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MoneyGram International reported revenue of $1,602.10MM vs $1,630.40MM (down 1.74%) and basic earnings per share -$0.47 vs $0.26. MoneyGram International is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.24. The estimated EPS forecast for the next fiscal year is $0.47 and is expected to report on March 15th, 2019.
To read the full MoneyGram International Inc. (MGI) report, download it here: http://Fundamental-Markets.com/register/?so=MGI
-----------------------------------------
BOOT BARN HOLDINGS, INC. (BOOT) REPORT OVERVIEW
Boot Barn's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Boot Barn reported revenue of $224.73MM vs $199.43MM (up 12.69%) and basic earnings per share $0.76 vs $0.40 (up 90.00%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, Boot Barn reported revenue of $629.82MM vs $569.02MM (up 10.68%) and basic earnings per share $0.54 vs $0.38 (up 42.11%). Boot Barn is expected to report earnings on May 15th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.12.
To read the full Boot Barn Holdings, Inc. (BOOT) report, download it here: http://Fundamental-Markets.com/register/?so=BOOT
-----------------------------------------
GREEN DOT CORPORATION (GDOT) REPORT OVERVIEW
Green Dot's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Green Dot reported revenue of $315.00MM vs $253.00MM (up 24.50%) and basic earnings per share $1.36 vs $0.81 (up 67.90%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Green Dot reported revenue of $890.15MM vs $718.77MM (up 23.84%) and basic earnings per share $1.70 vs $0.82 (up 107.32%). Green Dot is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.91 and is expected to report on February 20th, 2019.
To read the full Green Dot Corporation (GDOT) report, download it here: http://Fundamental-Markets.com/register/?so=GDOT
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
(0)
(0)